In Brief: Mifepristone by Mail for Pregnancy Termination

Date: January 24, 2022
Issue #: 
1642Summary: 
The FDA has removed the requirement that
mifepristone (Mifeprex, and generics), a progestin
receptor antagonist approved for use in a regimen with
the prostaglandin E1 analog misoprostol (Cytotec,
and generics) for medical termination of pregnancy,
must be dispensed in person to the patient.

Source: The Medical Letter - January 7, 2022 Category: Drugs & Pharmacology Authors: admin Tags: Mifegymiso Mifeprex Mifepristone Source Type: research